Physician profile
Gregory A Black
NPI 1538162375
$3,026.44
in general payments reported to CMS, 2019-2025
28 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $535 · 2021: $542 · 2022: $342 · 2023: $374 · 2024: $264 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $861.35 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Stryker Corporation | $466.27 | 2019-2024 | Citrefix, Viaflow, Variax |
| Smith+Nephew, INC. | $347.82 | 2019-2023 | Pico |
| Integra Lifesciences Corporation | $168.51 | 2019-2023 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Horizon Therapeutics Plc | $141.02 | 2020-2022 | |
| Medtronic USA, INC. | $125.45 | 2019 | |
| Paragon 28, INC. | $106.13 | 2019-2024 | R3flex, Additive Orthopedics |
| Paratek Pharmaceuticals, INC. | $90.75 | 2021-2025 | Nuzyra |
| Orthofix Medical, INC. | $82.00 | 2019-2022 | |
| Alfasigma USA, INC. | $71.79 | 2021-2022 | |
| Rock Medical Orthopedics, INC. | $68.97 | 2021 | |
| Mimedx Group, INC. | $57.09 | 2024-2025 | |
| Depuy Synthes Sales INC. | $53.68 | 2022-2024 | Healix Knotless Peek, Gii, Dynacord |
| Bioventus LLC | $50.92 | 2021-2022 | |
| Nevro Corp. | $49.23 | 2023-2024 | Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $44.58 | 2019 | |
| Celularity INC. | $31.45 | 2019-2020 | |
| Convatec INC. | $29.11 | 2023 | |
| Polarityte, INC. | $26.19 | 2019 | |
| Kerecis Limited | $26.18 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $23.53 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.09 | 2021 | |
| Becton, Dickinson and Company | $18.06 | 2022 | |
| Solventum Corporation | $17.63 | 2024 | Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $13.49 | 2025 | |
| Nabriva Therapeutics, Plc | $12.70 | 2022 | |
| Merck Sharp & Dohme LLC | $12.30 | 2019 | |
| Crossroads Extremity Systems, LLC | $9.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.